Key takeaways
Oral semaglutide (Rybelsus) and injectable semaglutide (Ozempic, Wegovy) contain the same active ingredient but differ in their form, dosage, and administration.
Injectable semaglutide may be more effective for both weight loss and blood sugar control.
The best choice between oral semaglutide vs. injection depends on your goals, lifestyle, and comfort. Oral semaglutide may be preferred by those looking to avoid needles, while injectable semaglutide offers stronger results and a more flexible dosing schedule.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Oral semaglutide (Rybelsus) and injectable semaglutide (Ozempic, Wegovy) contain the same active ingredient but differ in their form, dosage, and administration.
Injectable semaglutide may be more effective for both weight loss and blood sugar control.
The best choice between oral semaglutide vs. injection depends on your goals, lifestyle, and comfort. Oral semaglutide may be preferred by those looking to avoid needles, while injectable semaglutide offers stronger results and a more flexible dosing schedule.
Semaglutide comes in two forms. Semaglutide tablets go by the brand name Rybelsus (and a soon-to-be-approved oral Wegovy). Injectable semaglutide is available as Ozempic and Wegovy. Beyond the brand names, what’s the difference between oral semaglutide vs. injectable?
A lot, actually. From their FDA-approved indications to dosage strengths, there are several differences between oral vs. injectable semaglutide — as well as some similarities. Below, we break it all down and offer tips for choosing between semaglutide pills vs. injections.
What is semaglutide and what does it do?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. When combined with diet and exercise, the medication works by controlling blood sugar levels, slowing down digestion, and reducing your appetite.
Semaglutide is currently available under three brand names, each of which the US Food and Drug Administration (FDA) has approved for different conditions:
Rybelsus, a daily oral tablet, is approved to improve blood sugar control and reduce cardiovascular risk in adults with type 2 diabetes
Ozempic, a weekly injection, is approved to improve blood sugar control in adults with type 2 diabetes, reduce cardiovascular risk in adults with type 2 diabetes and heart disease, and slow kidney decline in adults with type 2 diabetes and chronic kidney disease
Wegovy, a weekly injection, is approved to reduce body weight in adults with obesity or overweight, lower cardiovascular risk in adults with heart disease and obesity or overweight, and treat fatty liver disease in adults
Oral vs. injectable semaglutide: key differences
| Oral semaglutide | Injectable semaglutide |
|---|---|---|
Brand names | Rybelsus | Ozempic, Wegovy |
FDA-approved indications | Control blood sugar levels in adults with type 2 diabetes (T2D)
Reduce cardiovascular risks in adults with T2D
| Ozempic: - Control blood sugar levels in adults with T2D - Cardiovascular risk in adults with T2D and heart disease - Kidney decline in adults with T2D and chronic kidney disease
Wegovy: - Weight loss in adults with obesity and overweight - Reduce cardiovascular risk in adults with heart disease and obesity or overweight - Fatty liver disease |
Frequency | Daily | Weekly |
How it’s taken | In the morning, 30 minutes before any food, water, or other medications | Subcutaneous injection on the same day each week |
Dosing | Formulation R1: 3 mg, 7 mg, 14 mg Formulation R2: 1.5 mg, 4 mg, 9 mg | Ozempic: 0.25 mg, 0.5 mg, 1 mg, 2 mg Wegovy: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg |
Common side effects | Nausea, stomach pain, diarrhea, decreased appetite, vomiting, constipation | Ozempic: Nausea, diarrhea, vomiting, constipation, stomach pain Wegovy: Nausea, diarrhea, vomiting, constipation, stomach pain or upset, dizziness, headache, fatigue, heartburn, gas |
Cost (without insurance) | $997.58 | Ozempic: $997.58 (list price) or $199-$499 (cash price) Wegovy: $1,349.02 (list price) or $199–$349 (cash price) |
Oral vs. injectable semaglutide: how they work and dosages
Oral and injectable semaglutide differ in their dosages and administration. But they work similarly since they have the same active ingredient.
How they work
Semaglutide medications work by mimicking GLP-1, a hormone naturally produced by your body. It targets GLP-1 receptors throughout your gastrointestinal tract, pancreas, and brain.
Specifically, semaglutide works by:
Slowing down digestion, so you feel full sooner
Regulating the release of insulin and glucagon after you eat to keep your blood sugar levels stable
Sending signals to your brain telling it that you’re full
Together, these effects help stabilize blood sugar levels and reduce appetite, making semaglutide an effective treatment for type 2 diabetes, obesity, and more.
When comparing oral semaglutide vs. injectable, it’s worth noting their difference in bioavailability — that is, how much of the drug enters your bloodstream. Semaglutide tablets have a much lower bioavailability than injections. This is one reason they need to be taken daily instead of weekly like injections.
Dosages
Oral semaglutide (Rybelsus) comes in two dosage formulations:
Formulation R1: 3 mg, 7 mg, 14 mg
Formulation R2: 1.5 mg, 4 mg, 9 mg
With either formulation, your healthcare provider may have you start at the lowest dosage strength. They will then slowly increase the dose (i.e. titrate up) every 30 days or so until you find a dosage that adequately controls your blood sugar levels.
For example, a typical dosage titration schedule for oral semaglutide (Rybelsus) might look like this:
| Formulation R1 | Formulation R2 |
|---|---|---|
Days 1–30 | 3 mg daily | 1.5 mg daily |
Days 31–60 | 7 mg daily | 4 mg daily |
Days 61+ | 14 mg daily | 9 mg daily |
Oral semaglutide for weight loss (Wegovy pill) will have a standard daily dose of 25 mg, according to Novo Nordisk, the manufacturer of oral and injectable semaglutide drugs.
Injectable semaglutide (Wegovy, Ozempic) has its own dosage strengths for each brand-name version:
Ozempic: 0.25 mg, 0.5 mg, 1 mg, 2 mg
Wegovy: 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, 2.4 mg
As with oral semaglutide, healthcare providers typically prescribe a low starting dosage. They then increase it every four weeks or so until you find a dosage that works for you.
For example, a typical dosage titration schedule for injectable semaglutide might look like this:
| Ozempic | Wegovy |
|---|---|---|
Weeks 1–4 | 0.25 mg weekly | 0.25 mg weekly |
Weeks 5–8 | 0.5 mg weekly | 0.5 mg weekly |
Weeks 9–12 | 1 mg weekly | 1 mg weekly |
Weeks 13–16 | 1 mg or 2 mg weekly | 1.7 mg weekly |
Weeks 16–20 | 1 mg or 2 mg weekly | 1.7 mg weekly or 2.4 mg weekly |
Weeks 20+ | 1 mg or 2 mg weekly | 2.4 mg weekly |
Administration
Oral semaglutide is taken once daily in the morning on an empty stomach. This is true for Rybelsus and the Wegovy pill.
Specifically, you should:
Avoid food, water, beverages, or medications for at least 30 minutes after taking oral semaglutide
Swallow oral semaglutide whole with a small amount of water (up to 4 ounces)
Injectable semaglutide is administered weekly via subcutaneous injection. That means you inject it under the skin into the fatty area on your abdomen, thigh, or upper arm.
Here’s what else you need to know:
You inject semaglutide every week, on the same day each week, at any time during that day (with or without food).
You should rotate injection sites weekly so that you’re not doing the injection in the exact same place every time.
If needed, you can change your semaglutide injection day, as long as it’s been at least two days since your last dose. It’s a good idea to check with your healthcare provider before changing your dosing day so they can help you make the change safely.
Oral vs. injectable semaglutide: side effects and risks
Semaglutide tablets and injections share many similar side effects, since they both contain semaglutide as the active ingredient.
The most common side effects of both oral and injectable semaglutide include
Abdominal pain
Diarrhea
Vomiting
Injectable semaglutide (Ozempic, Wegovy) may also cause reactions at the injection site, such as rash or irritation. But these are rare.
Both oral and injectable semaglutide carry similar risks, including:
Acute pancreatitis
Diabetic retinopathy complications (diabetes-related vision changes)
Hypoglycemia (low blood sugar), especially when used with insulin
Kidney or gallbladder issues
Severe gastrointestinal reactions
Allergic reactions
Pulmonary aspiration during general anesthesia or deep sedation
Additionally, Wegovy carries warnings for increased heart rate and suicidal behavior or ideation.
All forms of semaglutide carry a black box warning for thyroid tumors based on animal studies. While it’s unknown if semaglutide has the same effect in humans, people with a personal or family history of thyroid cancer should not take oral or injectable semaglutide.
Which is more effective for weight loss: oral or injectable semaglutide?
Injectable semaglutide, particularly Wegovy, may be more effective for weight loss than oral semaglutide, according to clinical trials.
In 68 weeks (about a year and a half), people taking Wegovy lost nearly 15% of their body weight (~34 pounds).
In roughly the same time frame, people taking oral semaglutide (Rybelsus) lost about 4.2% of their body weight (7.5 pounds).
In 64 weeks (about a year and three months), people taking oral semaglutide (Wegovy pill) lost 13.6% of their body weight (~31 pounds).
Which is more effective for blood sugar control: oral or injectable semaglutide?
Injectable semaglutide may be slightly more effective for blood sugar control than oral semaglutide, according to clinical trials.
Oral semaglutide (Rybelsus) reduces HbA1c levels by 1.2%–1.4% at week 26, depending on the dosage strength you’re taking.
Injectable semaglutide (Ozempic) reduces HbA1c levels by 1.4%–1.6% at week 30, again depending on the dosage strength.
So, in nearly the same amount of time, injectable semaglutide reduced blood sugar levels to a larger extent.
However, other studies have found that the difference in blood sugar control between oral vs. injectable semaglutide is not statistically significant.
Will there be more oral semaglutide options soon?
Yes. In fact, the FDA is expected to approve an oral semaglutide specifically for weight loss (Wegovy pill) by the end of 2025.
In May 2025, Novo Nordisk, the maker of Rybelsus, Wegovy, and Ozempic, applied for FDA approval of an oral version of Wegovy. The manufacturer did this after completing a 64-week OASIS 4 phase 3 trial. It found that 25 mg of oral Wegovy daily 25 mg of oral Wegovy reduced body weight by 13.6% in 64 weeks (about a year and three months).
“Most of my diabetics prefer Ozempic injection to the Rybelsus pill, both of which are semaglutide variants,” says Jennifer Brown, MD, ABOM, ABFM, a dual board-certified physician in family medicine and obesity medicine. “It will be interesting to see if real-world patients prefer Wegovy injections over oral Wegovy.”
Choosing between oral and injectable semaglutide: 5 factors
Choosing the best form of semaglutide for you — semaglutide pills vs. injection — depends on your medical situation, lifestyle, and personal preferences. Here are some of the key decision factors to consider:
1. Your weight loss goals. If your main goal is to lose weight, injectable semaglutide, particularly Wegovy, is likely your best bet. Wegovy can drive nearly 15% weight loss over a year and a half. While Ozempic and Rybelsus can drive some weight loss, it’s not as significant as Wegovy.
2. Your comfort with injections. To take Ozempic or Wegovy, you’ll need to inject yourself once a week. Oral semaglutide can be a preferred option for people who have an aversion to injections, Dr. Brown says.
3. Your lifestyle (vs. administration). Frequent flyer? A shelf-stable treatment may be a better fit for you. Oral semaglutide is taken daily and doesn’t need to be refrigerated. But the rigidity of oral semaglutide’s morning administration can be a downside for some people, Dr. Brown says. Sound like you? In that case, injectable semaglutide may be more up your alley, as it’s taken weekly. Just remember: It needs to be kept at certain temperatures.
4. Other medical conditions. Health insurance plans typically only cover a medication when it’s prescribed for an FDA-approved condition. In other words, it might be tougher to get Ozempic covered for weight loss than Wegovy. However, both forms of injectable semaglutide are approved to treat a number of conditions. Your healthcare provider can help you determine your best bet at securing coverage.
5. Your insurance coverage and budget. Oral and injectable semaglutide drugs have relatively high list prices: $997.58 for Rybelsus, $997.58 for Ozempic, and $1,349.02 for Wegovy. Novo Nordisk offers savings programs for certain brand-name drugs, but they come with eligibility requirements. You can also get injectable semaglutide for a reduced price if you pay with cash. Through Ro, for example, Wegovy pens cost $199-$349 per month when you opt for self-pay.
Which option may be best for you: oral or injectable semaglutide?
Your healthcare provider can help you determine whether oral or injectable semaglutide may be a better fit for you, based on your personal health situation and goals.
Oral semaglutide may be better if:
You have needle phobia or don’t like injections
You don’t want to worry about storing or properly disposing of needles and pens
You like the routine of taking a daily pill
Your main goal is to treat type 2 diabetes, with less of a need for weight loss
Your health insurance offers better coverage for Rybelsus vs. Ozempic or Wegovy
Injectable semaglutide may be better if:
You prefer the flexibility of only having to do an injection once a week, at any time of day
You don’t want to wait 30 minutes every morning before eating, drinking, or taking other medication after your oral semaglutide dose
You’re not taking other medications that have to be taken in the morning
You want greater blood sugar control or weight loss results
You also have fatty liver disease, chronic kidney disease, or heart disease
Bottom line
By now, you should be well-versed in oral semaglutide vs. injectable semaglutide. But after reading so much information, it can be hard to remember the high-level highlights. Hey, we get it. So, here are the main differences and similarities between oral and injectable semaglutide to help keep them top-of-mind:
They work the same. Oral semaglutide and injections both work by mimicking the GLP-1 hormone to help control blood sugar, slow digestion, and reduce appetite.
Dosage strengths differ. Each form of semaglutide comes in different dosage strengths, but they’re all titrated up gradually until you find an effective dosage.
Dosing frequency and administration differ. Oral semaglutide is taken daily in the morning on an empty stomach (at least 30 minutes before food, water, and other medications), while injections are done weekly at any time of day.
Side effects are similar. Gastrointestinal side effects are common with both oral and injectable semaglutide. Semaglutide injections may also cause injection site reactions, and Wegovy has a longer list of side effects in general.
Semaglutide injections may produce more weight loss. Injectable semaglutide (especially Wegovy) may be more effective at weight loss and slightly more effective at blood sugar control.
Frequently asked questions (FAQs)
How does semaglutide help weight loss?
Semaglutide helps with weight loss by slowing down digestion, so you feel full sooner. It also reduces appetite by sending satiety (fullness) signals to your brain. Thanks to these effects, people may eat less and lose weight as a result.
How much weight can you lose on injectable semaglutide?
Based on clinical trials, you can lose up to 15% of your body weight on injectable semaglutide 2.4 mg (Wegovy) over 68 weeks (about a year and a half).
What are the main differences between oral and injectable semaglutide?
Oral semaglutide is a daily pill, while injectable semaglutide is injected once a week. Injectable semaglutide may produce slightly more weight loss and greater blood sugar control, but oral semaglutide may be preferred by those who don’t like needles.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
Ozempic Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
References
Bonora, B. M., Russo, G., Leonetti, F., et al. (2024). Effectiveness of oral semaglutide on glucose control and body weight up to 18 months: a multicenter retrospective real-world study. Journal of Endocrinological Investigation, 47(6), 1395–1403. doi: 10.1007/s40618-024-02309-2. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11142994/
Chubb, B., Gupta, P., Gupta, J., et al. (2021). Once-Daily Oral Semaglutide Versus Injectable GLP-1 RAs in People with Type 2 Diabetes Inadequately Controlled on Basal Insulin: Systematic Review and Network Meta-analysis. Diabetes Therapy, 12(5), 1325–1339. doi: 10.1007/s13300-021-01034-w. Retrieved from https://link.springer.com/article/10.1007/s13300-021-01034-w
Kommu, S. & Whitfield, P. (2024). Semaglutide. StatPearls. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK603723/
Novo Nordisk. (2025). Press Release: FDA accepts filing application for oral semaglutide 25 mg, which if approved, would be the first oral GLP-1 treatment for obesity. Retrieved from https://www.novonordisk-us.com/media/news-archive/news-details.html?id=915988
NovoCare-a. (2025). Find out the cost for Ozempic. Retrieved from https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html
NovoCare-b. (2025). Find out the cost for Rybelsus. Retrieved from https://www.novocare.com/diabetes/products/rybelsus/explaining-list-price.html
NovoCare-c. (2025). Get savings and support for Ozempic. Retrieved from https://www.novocare.com/diabetes/products/ozempic/savings-offer.html
NovoCare-d. (2025). What is the list price for Wegovy and will it impact me?. Retrieved from https://www.novocare.com/obesity/products/wegovy/let-us-help/explaining-list-price.html
U.S. Food and Drug Administration (FDA-a). (2025). Highlights of Prescribing Information: Rybelsus (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/213051s024,s028s029lbl.pdf
U.S. Food and Drug Administration (FDA-b). (2025). Highlights of Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/209637s035,209637s037lbl.pdf
U.S. Food and Drug Administration (FDA-c). (2025). Highlights of Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215256s024lbl.pdf
Wharton, S., Lingvay, I., Bogdanski, P., et al. (2025). Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. The New England Journal of Medicine, 393(11), 1077–1087. doi: 10.1056/NEJMoa2500969. Retrieved from https://pubmed.ncbi.nlm.nih.gov/40934115/
Wilding, J. P., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. doi: 10.1056/nejmoa2032183. Retrieved from https://www.nejm.org/doi/10.1056/NEJMoa2032183














